Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

被引:351
作者
Velázquez, RF
Rodríguez, M
Navascués, CA
Linares, A
Pérez, R
Sotorríos, NG
Martínez, I
Rodrigo, L
机构
[1] Hosp Cent Asturias, Dept Gastroenterol, Oviedo 33006, Asturias, Spain
[2] Hosp Cabuenes, Dept Gastroenterol, Gijon, Spain
关键词
D O I
10.1053/jhep.2003.50093
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Better knowledge of the risk factors associated with the appearance of hepatocellular carcinoma (HCC) could improve the efficacy of surveillance programs. A total of 463 patients aged 40 to 65 years with liver cirrhosis in Child-Pugh class A or B were included in a program of early diagnosis. The predictive value of different risk factors was evaluated using the Kaplan-Meier method and Cox regression model. Thirty-eight patients developed HCC. In the multivariate analysis, 4 variables showed an independent predictive value for the development of HCC: age 55 years or older, antibody to hepatitis C virus (anti-HCV) positivity, prothrombin activity 75% or less, and platelet count less than 75 X 10(3)/mm(3). According to the contribution of each of these factors to the final model, a score ranging between 0 and 4.71 points was constructed to allow the division of patients into 2 different risk groups. The low-risk group included those with a score of 2.33 points or less (n = 270; 4 with HCC; cumulative incidence of HCC at 4 years, 2.3%), and the high-risk group included those with a score greater than 2.33 (n = 193; 34 with HCC; cumulative incidence of HCC at 4 years, 30.1%) (P = .0001). In conclusion, a simple score made up of 4 clinical and biological variables allowed us to distinguish 2 groups of cirrhotic patients at high and low risk for the development of HCC. We believe this score can be useful in establishing a subset of cirrhotic patients in whom a surveillance program for early detection of HCC could be unjustified.
引用
收藏
页码:520 / 527
页数:8
相关论文
共 52 条
[11]   HEPATOCELLULAR-CARCINOMA IN ITALIAN PATIENTS WITH CIRRHOSIS [J].
COLOMBO, M ;
DEFRANCHIS, R ;
DELNINNO, E ;
SANGIOVANNI, A ;
DEFAZIO, C ;
TOMMASINI, M ;
DONATO, MF ;
PIVA, A ;
DICARLO, V ;
DIOGUARDI, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) :675-680
[12]   Hepatitis C virus and hepatocellular carcinoma [J].
Colombo, M .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :263-269
[13]   SCREENING FOR HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CHILDS-A-CIRRHOSIS - AN 8-YEAR PROSPECTIVE-STUDY BY ULTRASOUND AND ALPHA-FETOPROTEIN [J].
COTTONE, M ;
TURRI, M ;
CALTAGIRONE, M ;
PARISI, P ;
ORLANDO, A ;
FIORENTINO, G ;
VIRDONE, R ;
FUSCO, G ;
GRASSO, R ;
SIMONETTI, RG ;
PAGLIARO, L .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1029-1034
[14]  
COX DR, 1972, J R STAT SOC B, V34, P187
[15]   IDENTIFICATION AND SCREENING OF 416 PATIENTS WITH CHRONIC HEPATITIS AT HIGH-RISK TO DEVELOP HEPATOCELLULAR CANCER [J].
CURLEY, SA ;
IZZO, F ;
GALLIPOLI, A ;
DEBELLIS, M ;
CREMONA, F ;
PARISI, V .
ANNALS OF SURGERY, 1995, 222 (03) :375-383
[16]   Hepatitis C and hepatocellular carcinoma [J].
DiBisceglie, AM .
HEPATOLOGY, 1997, 26 (03) :S34-S38
[17]   High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity [J].
Donato, MF ;
Arosio, E ;
Del Ninno, E ;
Ronchi, G ;
Lampertico, P ;
Morabito, A ;
Balestrieri, MR ;
Colombo, M .
HEPATOLOGY, 2001, 34 (03) :523-528
[18]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[19]   High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors [J].
Fasani, P ;
Sangiovanni, A ;
De Fazio, C ;
Borzio, M ;
Bruno, S ;
Ronchi, G ;
Del Ninno, E ;
Colombo, M .
HEPATOLOGY, 1999, 29 (06) :1704-1707
[20]  
FATTOVICH G, 1995, HEPATOLOGY, V21, P77